[ad_1]
Penn State College of Medicine In vitro study shows very promising results
WINNIPEG, MB, March 24, 2021 / CNW / – Innotech Nutrition, a Canadian manufacturer of natural health products, is delighted to release the results of a Penn State College of Medicine research study which showed that the company’s COLFLEX oral spray inactivated 99-99.9% of the infectious human coronavirus 229E.
The study was conducted by Dr. Craig meyers and his scientific team at Penn State University. He examined the two variants of Innotech Nutrition’s COLFLEX oral sprays, examining the effect of the sprays on the human coronavirus 229E at a contact time of two minutes. The study showed promising results that the products were very effective during this time and were over 90% effective in inactivating the virus at a contact time of 60 seconds.
Human coronavirus 229E is one of seven coronaviruses that can infect people, according to the Center for Disease Control of United States (source: https://www.cdc.gov/coronavirus/types.html). It is one of the main causes of colds and respiratory tract infections. Coronaviruses are named for the crown-shaped spikes on their surface. Dr. Meyers’ research has shown that compounds effective at inactivating 229E generally act in a similar way against other human coronaviruses, including SARS-CoV-2, which is the novel coronavirus responsible for the disease better known as of COVID-19.
According to Meyers, the results of these oral sprays are promising and add to the results of a previous study showing that certain types of oral rinses could inactivate HCoV229E under similar experimental conditions.
“The next step in developing these results is to design and conduct clinical trials that evaluate whether products such as these oral throat sprays can actually lower viral load in patients,” Meyers said.
As in previous similar studies, the Penn State The scientific team prepared a standard laboratory test (viral inactivation tests) to reproduce the interaction of the virus in the throat and oral cavity, with the product as an oral spray. The throat and oral cavities are the main points of entry and transmission of human coronaviruses.
“We are excited about the Penn State research on our products and look forward to further research, ”said Wayne friesen, president of Innotech Nutrition. “Although this study shows very promising results, it should in no way be interpreted as a form of prevention of COVID-19. We all use Colflex regularly with ourselves and our families, we like to think of it as an extra layer of protection or another tool in your toolbox. We strongly encourage everyone to continue to practice all public health measures currently in place and to follow the advice of your healthcare professionals closely. It may sound old fashioned, but it also doesn’t. Don’t forget your mom’s common sense advice on eating healthy, getting enough sleep, staying hydrated, and keeping a smile. “
Innotech Nutrition’s COLFLEX oral spray is a natural health product approved by Health Canada and has been on the market since 2012. In a previous scientific study, conducted in 2017, the product was shown to kill staphylococcus, streptococcal pneumonia , e-coli and salmonella. and has been successfully tested for a comprehensive safety analysis at University of Manitoba (source: Winnipeg Free Press https://www.winnipegfreepress.com/business/throat-spray-proven-effective-for-fighting-cold-flu-454627533.html)
For more information on Innotech Nutrition products, visit www.innotechnutrition.com
SOURCE Innotech Nutrition
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2021/24/c3812.html
Source link
